The long term goal of the proposed research is to understand the effect of flow, fluid mechanical stresses and mechanical strain on the arachidonic acid metabolism of endothelial cells and leukocytes and subsequent modulation of endothelia cell gene expression and platelet and leukocyte interactions with endothelial cells. Initial studies from our laboratory have indicated quite striking stress-metabolism coupling in each of these cell types. Proposed work will center on understanding the mechanisms of membrane signal transduction and gene regulation for these unique (and physiologically relevant) stimuli. Potential mediators include alteration of ion fluxes across cell membranes caused by mechanical perturbations (including stretch activated ion channels), with calcium, potassium and hydrogen ion regulation being most likely. Three dimensional reconstructions of intracellular calcium and pH distribution will be obtained utilizing fluorescence video reconstructions of intracellular calcium and pH distribution will be obtained utilizing fluorescence video microscopy coupled with digital image processing. We hypothesize that both the level of stress (and strain) and the ate of change of stress (and strain) acting on the cell membrane are important factors in modulation of time, stress (strain) magnitude and the time history of stress (strain) applications. Specifically designed viscometers, flow chambers, and uniaxial stretching chambers will be employed. At the gene regulation level, polymerase chain reaction methods and northern analysis will be employed to ascertain changes in steady state messenger RNA levels caused by mechanical perturbations. Altered levels of secretion of metabolites, such as tPA, PAI-1 and endothelia, in addition to expression of membrane associated adhesion receptors caused by fluid flow and strain will be quantified. Again, preliminary data from our laboratory have documented changes in secretion of many potent vasoactive compounds. The roles of flow and strain on expression of cell adhesion molecules such as ICAM-I, VCAM-1 and P- and E-selectin-- as well as modulation of subsequent neutrophil adhesion may be very important in stroke pathophysiology. We will extend our studies of human umbilical vein and bovine pulmonary and aortic endothelial cells to a newly developed bovine brain endothelium preparation. Studies of flow and arachidonic acid metabolite control of the permeability of endothelial cell monolayers from these different vascular beds will be conducted in specially designed flow chambers with nuclepore membrane inserts. Comparison of flow and strain regulation of metabolism in these different cell types will be important with respect to in vivo stroke applications. We believe our results should be of importance in understanding the role of flow in metabolic events associated with ischemia and reperfusion. Many of the metabolites produced are extremely bioactive and can lead to changes in vessel permeability, cell adhesion and smooth muscle tone-all of which may be important in the pathogenesis of stroke.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS023327-13
Application #
6273735
Study Section
Project Start
1998-02-01
Project End
1999-01-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
13
Fiscal Year
1998
Total Cost
Indirect Cost
City
Houston
State
TX
Country
United States
Zip Code
77225
Chen, Pei-Feng; Wu, Kenneth K (2009) Two synthetic peptides corresponding to the proximal heme-binding domain and CD1 domain of human endothelial nitric-oxide synthase inhibit the oxygenase activity by interacting with CaM. Arch Biochem Biophys 486:132-40
Wu, Jui-Sheng; Cheung, Wai-Mui; Tsai, Yau-Sheng et al. (2009) Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation. Circulation 119:1124-34
Liou, Jun-Yang; Ellent, David P; Lee, Sang et al. (2007) Cyclooxygenase-2-derived prostaglandin e2 protects mouse embryonic stem cells from apoptosis. Stem Cells 25:1096-103
Cieslik, Katarzyna A; Deng, Wu-Guo; Wu, Kenneth K (2006) Essential role of C-Rel in nitric-oxide synthase-2 transcriptional activation: time-dependent control by salicylate. Mol Pharmacol 70:2004-14
Deng, Wu-Guo; Tang, Shao-Tzu; Tseng, Hui-Ping et al. (2006) Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood 108:518-24
Wu, Kenneth K (2006) Analysis of protein-DNA binding by streptavidin-agarose pulldown. Methods Mol Biol 338:281-90
Lin, Teng-Nan; Cheung, Wai-Mui; Wu, Jui-Sheng et al. (2006) 15d-prostaglandin J2 protects brain from ischemia-reperfusion injury. Arterioscler Thromb Vasc Biol 26:481-7
Wu, Kenneth K (2006) Transcription-based COX-2 inhibition: a therapeutic strategy. Thromb Haemost 96:417-22
Liou, Jun-Yang; Lee, Sang; Ghelani, Dipak et al. (2006) Protection of endothelial survival by peroxisome proliferator-activated receptor-delta mediated 14-3-3 upregulation. Arterioscler Thromb Vasc Biol 26:1481-7
Liou, Jun-Yang; Aleksic, Nena; Chen, Shu-Fen et al. (2005) Mitochondrial localization of cyclooxygenase-2 and calcium-independent phospholipase A2 in human cancer cells: implication in apoptosis resistance. Exp Cell Res 306:75-84

Showing the most recent 10 out of 63 publications